Page last updated: 2024-10-25

chlorpyrifos and Myelodysplastic Syndromes

chlorpyrifos has been researched along with Myelodysplastic Syndromes in 1 studies

Chlorpyrifos: An organothiophosphate cholinesterase inhibitor that is used as an insecticide and as an acaricide.
chlorpyrifos : An organic thiophosphate that is O,O-diethyl hydrogen phosphorothioate in which the hydrogen of the hydroxy group has been replaced by a 3,5,6-trichloropyridin-2-yl group.

Myelodysplastic Syndromes: Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jafari, K1
Tierens, A1
Rajab, A1
Musani, R1
Schuh, A1
Porwit, A1

Other Studies

1 other study available for chlorpyrifos and Myelodysplastic Syndromes

ArticleYear
Visualization of Cell Composition and Maturation in the Bone Marrow Using 10-Color Flow Cytometry and Radar Plots.
    Cytometry. Part B, Clinical cytometry, 2018, Volume: 94, Issue:2

    Topics: Adult; Aged; Bone Marrow; Bone Marrow Cells; Cell Differentiation; Cohort Studies; Color; Female; Fl

2018